5/10
03:31 am
cah
Cardinal Health, Inc. (NYSE: CAH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Cardinal Health, Inc. (NYSE: CAH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
5/8
05:06 am
cah
Global Contact Layer Dressings Market Report 2023-2030: Focus on Region, Country-Level Analysis, and Competitive Landscape [Yahoo! Finance]
Low
Report
Global Contact Layer Dressings Market Report 2023-2030: Focus on Region, Country-Level Analysis, and Competitive Landscape [Yahoo! Finance]
5/7
04:15 pm
cah
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
Low
Report
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
5/7
05:49 am
cah
Medical Supply Delivery Service Market to surpass $112.09 billion by 2031, at a CAGR of 8.1%, says Coherent Market Insights [Yahoo! Finance]
Low
Report
Medical Supply Delivery Service Market to surpass $112.09 billion by 2031, at a CAGR of 8.1%, says Coherent Market Insights [Yahoo! Finance]
5/6
10:48 am
cah
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock [Yahoo! Finance]
Low
Report
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock [Yahoo! Finance]
5/6
07:50 am
cah
3 Eaton Vance Mutual Funds for Reliable Returns [Yahoo! Finance]
Low
Report
3 Eaton Vance Mutual Funds for Reliable Returns [Yahoo! Finance]
5/3
01:32 pm
cah
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Evercore ISI from $110.00 to $115.00. They now have an "in-line" rating on the stock.
Low
Report
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Evercore ISI from $110.00 to $115.00. They now have an "in-line" rating on the stock.
5/3
10:28 am
cah
Cardinal Health, Inc. (NYSE:CAH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Cardinal Health, Inc. (NYSE:CAH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
08:07 am
cah
Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Robert W. Baird from $134.00 to $128.00. They now have an "outperform" rating on the stock.
Medium
Report
Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Robert W. Baird from $134.00 to $128.00. They now have an "outperform" rating on the stock.
5/3
07:58 am
cah
Cardinal Health Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Medium
Report
Cardinal Health Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
5/2
01:42 pm
cah
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
5/2
11:44 am
cah
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View [Yahoo! Finance]
Low
Report
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View [Yahoo! Finance]
5/2
09:07 am
cah
Frontline Flex Pay, Powered by Wagestream Now Available to All K-12 District Employees [Yahoo! Finance]
Low
Report
Frontline Flex Pay, Powered by Wagestream Now Available to All K-12 District Employees [Yahoo! Finance]
5/2
08:56 am
cah
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs [Reuters]
Low
Report
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs [Reuters]
5/2
08:45 am
cah
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs [Yahoo! Finance]
Low
Report
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs [Yahoo! Finance]
5/2
06:55 am
cah
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance [Yahoo! Finance]
Low
Report
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance [Yahoo! Finance]
5/2
06:45 am
cah
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
Medium
Report
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
5/2
02:05 am
cah
Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
5/1
10:33 am
cah
Enteral Feeding Devices Market Worth $5.6 billion | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Enteral Feeding Devices Market Worth $5.6 billion | MarketsandMarkets™ [Yahoo! Finance]
4/30
01:55 pm
cah
The US Medical Face Shields Market to Worth $158.16 Billion by 2029 - Pandemic Drives Explosive Growth in Online Sales Transforming Industry Landscape- Exclusive Focus Research Report by Arizton [Yahoo! Finance]
Low
Report
The US Medical Face Shields Market to Worth $158.16 Billion by 2029 - Pandemic Drives Explosive Growth in Online Sales Transforming Industry Landscape- Exclusive Focus Research Report by Arizton [Yahoo! Finance]
4/30
08:17 am
cah
Genstar Names Keith Martino to Strategic Advisory Board [Yahoo! Finance]
Low
Report
Genstar Names Keith Martino to Strategic Advisory Board [Yahoo! Finance]
4/29
03:03 pm
cah
Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Wells Fargo & Company from $96.00 to $94.00. They now have an "underweight" rating on the stock.
Low
Report
Cardinal Health, Inc. (NYSE: CAH) had its price target lowered by analysts at Wells Fargo & Company from $96.00 to $94.00. They now have an "underweight" rating on the stock.
4/29
01:58 pm
cah
What's in Store for Cardinal Health (CAH) in Q3 Earnings? [Yahoo! Finance]
Low
Report
What's in Store for Cardinal Health (CAH) in Q3 Earnings? [Yahoo! Finance]
4/29
10:50 am
cah
Seeking Clues to Cardinal (CAH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics [Yahoo! Finance]
Low
Report
Seeking Clues to Cardinal (CAH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics [Yahoo! Finance]
4/26
02:44 pm
cah
FDA Roundup: April 26, 2024 [Yahoo! Finance]
Low
Report
FDA Roundup: April 26, 2024 [Yahoo! Finance]